Scientific Publications
Filter:
Artificial Intelligence for Home Monitoring Devices
Keenan, Tiarnan D.L.; Loewenstein, Anat. Artificial intelligence for home monitoring devices. Current Opinion in Ophthalmology ():10.1097/ICU.0000000000000981, June 20, 2023. | DOI: 10.1097/ICU.0000000000000981
The Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study
Ho A, Schechet S, Mathai M, Reddy S, Elman MJ, Garfinkel RA, Ladd, B Wagner A, Sanborn GE, Jacobs J, Busquets M, Chew EY. The Predictive Value of False-Positive ForeseeHome Alerts in the ALOFT Study, Ophthalmology Retina 2022. doi: https:// doi.org/10.1016/j.oret.2022.10.009
Analysis of the Long-term visual Outcomes of ForeseeHome Remote Telemonitoring - The ALOFT study
Mathai M, Reddy S, Elman MJ, Garfinkel RA, Ladd B, Wagner A, Sanborn GE, Jacobs J, Busquets M, Chew EY; ALOFT study group. Analysis of the Long-term visual Outcomes of ForeseeHome Remote Telemonitoring - The ALOFT study, Ophthalmology Retina. 2022;6:922-929. doi: https://doi.org/10.1016/j.oret.2022.04.016.
Current status of home monitoring technology for age-related macular degeneration
Busquets MA, Sabbagh O. Current status of home monitoring technology for age-related macular degeneration. Curr Opin Ophthalmol. Mar 2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
Ho AC, Heier JS, Holekamp NM, et al. Real-World performance of a self-operated home monitoring system for early detection of neovascular age-related macular degeneration. J Clin Med. 2021;10(7):1355. March, 2021. https://www.mdpi.com/2077-0383/10/7/1355
FDA Intended Use
ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.
